Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 27 February 2001
Vol. 2001, Issue 71, p. tw12
[DOI: 10.1126/stke.2001.71.tw12]


Receptor Biology {Delta}EGFR with Sugar on Top

An epidermal growth factor receptor (EGFR) mutant (EGFRvIII/{Delta}EGFR) harboring a large deletion of the EGFR extracellular domain is frequently found in several types of cancer. The kinase activity in the mutant no longer depends on EGF binding, and thus, the kinase is constitutively active but weaker. Fernandes et al. found that, in contrast to previous reports, the kinase activity of the mutant is at least as active as wild-type (wt) EGFR, and they may have uncovered a mechanism for the constitutive activation of {Delta}EGFR. Both wt EGFR from EGF-treated cells and {Delta}EGFR were immunoprecipitated with an antibody that specifically recognizes the catalytically active form of the receptor. Phosphopeptide mapping revealed that the same tyrosine residues were phosphorylated in wt and {Delta}EGFR, and to similar stoichiometric levels. In the absence of EGF, {Delta}EGFR but not wt EGFR formed activated dimers. Fernandes et al. found that glycosylation was also important for mediating an active conformation and consequent {Delta}EGFR kinase activity. But is glycosylation continuously required for kinase activity or does it simply allow formation of a stable active conformation then become dispensable? The authors showed that the function of glycosylation is to permit the proper conformation of each subunit in the dimer; deglycosylation of active {Delta}EGFR dimers did not affect their kinase activity, nor did the dimers dissociate. Tunicamycin-treated {Delta}EGFR (prevented from undergoing de novo glycosylation) was unable to form dimers, suggesting that glycosylation is required for the constitutive activation of {Delta}EGFR.

H. Fernandes, S. Cohen, S. Bishayee, Glycosylation-induced conformational modification positively regulates receptor-receptor association: A study with an aberrant epidermal growth factor receptor (EGFRvIII/{Delta}EGFR) expressed in cancer cells. J. Biol. Chem. 276, 5375-5383 (2001). [Abstract] [Full Text]

Citation: {Delta}EGFR with Sugar on Top. Sci. STKE 2001, tw12 (2001).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882